🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Study on a Novel Strategy of Individualized Non-Invasive Neuromodulation for the Treatment of Tic Disorders in Children

RecruitingNAAges 5 Months - 18 YearsAllShanghai Children's Medical Center
NCT07351955 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to establish a novel personalized closed-loop NiBS/TMS therapeutic strategy and clinical protocol for children with Tic Disorders (TDs) through a series of scientific investigations. Additionally, it seeks to elucidate the underlying neural circuit mechanisms, enhance the therapeutic efficacy of TMS in pediatric TDs, and achieve precision neuromodulation for children with TDs.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 1: Children and adolescents aged 5 to 18 years 2: Meets DSM-5 diagnostic criteria for Tic Disorders (TDs) with normal EEG findings 3: No prior treatment received for TDs 4: Full-scale intelligence quotient (FIQ) ≥70 on the Wechsler Intelligence Scale for Children-Revised (WISC-R) Exclusion Criteria: * 1: WISC-R Full-Scale Intelligence Quotient (FIQ) \<70 2: Presence of metal implants in the body ，Non-right-handedness 3: Head movement (HM) \>2mm during fMRI scanning, including both translational movement (TM) and rotational movement (RM) 4: Any other neurological or psychiatric conditions, including but not limited to autism spectrum disorder (ASD), epilepsy, obsessive-compulsive disorder (OCD), etc 5: Previous head trauma ，Neurological diseases ，Major systemic illnesses
💊

What it tests

  • Transcranial Magnetic Stimulation
  • general behavioral therapy
📍

Where

1 site
Shanghai Children's Medical Center，School of Medicine, Shanghai Jiao Tong University
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy